TY - JOUR
T1 - Normalisation of high CA 19-9 values in autoimmune hepatitis after steroidal treatment.
AU - Montalto, Massimo
AU - Santoro, Luca
AU - Vastola, Monica
AU - Curigliano, Valentina
AU - Ricci, Riccardo
AU - Vecchio, Fabio Maria
AU - Manna, Raffaele
AU - Gasbarrini, Giovanni Battista
PY - 2005
Y1 - 2005
N2 - Carbohydrate 19-9 antigen (CA 19-9) is considered a specific marker of pancreatobiliary adenocarcinomas, but slight increase of its levels can be found in several non-malignant diseases of the liver, such as autoimmune hepatitis. We describe a case of marked CA 19-9 elevation (up to 898.0 U/ml) in a patient with autoimmune hepatitis. Laboratory and instrumental examinations excluded malignant diseases. Immunohistochemical analysis for CA 19-9 and MIB-1, performed on liver biopsy, showed reactivity in inflammatory areas, in particular in bile ductule cells and hepatocytes in ductular metaplasia, suggesting that these cells could be involved in CA 19-9 serum levels increase. After steroids, the clinical picture improved and all the laboratory parameters normalised.
AB - Carbohydrate 19-9 antigen (CA 19-9) is considered a specific marker of pancreatobiliary adenocarcinomas, but slight increase of its levels can be found in several non-malignant diseases of the liver, such as autoimmune hepatitis. We describe a case of marked CA 19-9 elevation (up to 898.0 U/ml) in a patient with autoimmune hepatitis. Laboratory and instrumental examinations excluded malignant diseases. Immunohistochemical analysis for CA 19-9 and MIB-1, performed on liver biopsy, showed reactivity in inflammatory areas, in particular in bile ductule cells and hepatocytes in ductular metaplasia, suggesting that these cells could be involved in CA 19-9 serum levels increase. After steroids, the clinical picture improved and all the laboratory parameters normalised.
KW - autoimmune hepatitis
KW - ca 19.9
KW - steroidal therapy
KW - autoimmune hepatitis
KW - ca 19.9
KW - steroidal therapy
UR - http://hdl.handle.net/10807/93111
U2 - 10.1177/039463200501800321
DO - 10.1177/039463200501800321
M3 - Article
SN - 0394-6320
VL - 18
SP - 603
EP - 607
JO - International Journal of Immunopathology and Pharmacology
JF - International Journal of Immunopathology and Pharmacology
ER -